Advertisement

Topics

Companies Related to "Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older" [Most Relevant Company Matches] - Page: 4 RSS

10:54 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Immunogenicity Commercially Available Influenza Vaccine Formulation 2006" Companies 76–100 of 2,500+

Relevant

AlphaVax, Inc.

AlphaVax, Inc. is a North Carolina-based, clinical-stage company that uses a proprietary alphavirus vector platform technology that has proven to be highly flexible and immunogenic, and allows the same manufacturing, formulation, and delivery strategies to be applied to many different products. The company's business strategy is to maximize the potential of this platform through a mixture of in-h...


FinnBrit Consulting

FinnBrit Consulting provides consulting/advisory/ troubleshooting services to the pharmaceutical and related industries. We guide you through your drug development program from preformulation through to process design, development and manufacturing to the eventual launch of the finished medicinal product. We can reverse engineer a formulation whether for issues relating to intellectual property is...

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T...


GeoVax Labs, Inc.

GeoVax is a biotechnology company developing human vaccines for diseases caused by HIV (Human Immunodeficiency Virus - that leads to AIDS) and other infectious agents. Our goals include developing HIV/AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting clinical trials for vaccine safety and effectiveness, and obtaining re...

BioPhorum 2006

Following on from the successful BioPhorum 2004 and 2005 meetings in Ireland and USA respectively, we are pleased to be able to provide details of the 2006 event.The meeting will be held from Tuesday 2nd May 2006 through Thursday 4th May at the Der Margarethenhof Hotel in Marienstein / Waakirchen, Germany. The closest international airport is Munich, and most participants are expected to arrive th...

Acambis

Acambis recognises the value of highly focused marketing efforts and is initially targeting the world's single largest vaccine market – the US – to maximise the return on our investment. In 2003, we acquired a North American vaccine sales, promotion and distribution company, Berna Products Corporation (BPC). BPC has the exclusive North American sales and distribution rights to the world's only...

Erimos Technologies, LLC

Erimos has exclusive license for nordihydroguaiaretic acid (NDGA) derivatives from The Johns Hopkins University. We have developed a novel process to extract NDGA from the resin of the leaves of Larrea tridentata, a desert plant indigenous to the southwestern US and Mexico. EM-1421, our lead candidate, is a semi-synthetic derivative of NDGA. It is designed to target specific differences between no...

Marinomed Biotechnologie GmbH

Marinomed is a biopharmaceutical company discovering and developing innovative anti-viral and immunological treatments. Marinomed develops therapies against respiratory diseases based on its innovative anti-viral respiratory technology platform mavirex. Safety and efficacy of the mavirex technology have already been proven in clinical trials. The huge potential of the technology is reflected by...

TapImmune, Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T...

WIL Research Company, Inc.

WIL Research Company, Inc. is a privately held global Contract Research Organization that provides product safety toxicological research, bioanalytical, and formulation services to the pharmaceutical, biotechnology, chemical, agrochemical, and food products industries as well as manufacturing support for clinical trials. www.wilholding.com

Total Safety

Total Safety, a DLJ Merchant Banking Partners portfolio company, based in Houston, Texas, is the world’s leading global provider of integrated safety strategies and the products necessary to support them: on-site safety services, turnaround safety support, gas detection, respiratory services, rescue services, safety training, fire services and engineered ...

OctoPlus N.V.

OctoPlus is a drug product development company that is globally renowned as a center of excellence in formulation development, drug delivery and manufacturing. We offer proven and reliable services in formulation development, analytical development, process development and GMP manufacturing. Our expertise is focused on formulation of biotech-derived compounds and small chemical molecules. In...

GenVec

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent-protected technology platform to deliver genes that produce medically beneficial proteins directly at the site of disease. TNFerade™ represents a novel approach to treating cancer in combination with rad...

Galenica AB

Galenica´s strategy is to enter as a highly qualified partner in all aspects of the development of new drugs. Galenica offers full coverage from traditional pharmaceutical formulation, formulation development, biopharmaceutical evaluation, GMP-manufacturing, quality control to regulatory elements of drug development.

Ergonomics and Safety

Ergonomics and Safety provides consulting services to companies for prevention of occupational injuries and illnesses. Ergonomics and Safety applies the following ergonomics tools to industrial and office environments for workplace design and development of safety programs

Dynavax Technologies

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative therapeutic products to treat and prevent infectious diseases, allergies, and cancer. Our versatile, proprietary approaches alter specific immune responses by activating a unique receptor called Toll-Like Receptor 9 (TLR9) found on certain immune system cells. To target TLR9, we are using immunostimulat...

IMAXIO SA

Imaxio develops therapeutic and theranostic products that address currently unmet medical needs, particularly in the field of infectious diseases and oncology. Our integrated infrastructure enables in-house development, production and marketing of vaccines. Our development is based on a core growth served by our product and services to the industry. We also strive to strengthen our company thr...

Vaxxas

Vaxxas is a privately-held biotechnology company focused on enhancing the performance of existing and next generation vaccines with its proprietary Nanopatch™ technology platform. Vaxxas’ Nanopatch contains an ultra-high density array of projections – invisible to the naked human eye – that are dry-coated with vaccine. Application of the ...

VGTI Florida

VGTI Florida is the Florida-funded expansion of Oregon Health & Science University's highly successful Vaccine and Gene Therapy Institute. Research at the facility will focus on vaccine development with a special focus on vaccines and therapeutics that protect the aging population, which is the most vulnerable to disease.

Affinivax, Inc.

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation, and working with world experts in vaccine discovery and development, Affinivax is focused on creati...

ARA Safety

ARA Safety is a world leader in innovative fire and life safety technology. ARA Safety's revolutionary Fire Interruption Technology (FIT) fire knock down tool is saving lives and reducing property loss in cities and towns across North America.

Alabama Outward Bound

Established in 2006 in Fairhope, Alabama. One of 12 United States based Outward Bound schools; AOBS offers courses with consistently high levels of learning, safety and results. www.alabamaoutwardboundschool.org.

Piramal Healthcare

We are a global custom manufacturing organization with sites in Canada, UK & India. We offer formulation services which include, 1. Preformulation studies 2. Formulation development 3. Clinical Trial Manufacturing 4. Clinical packaging 5. Commercial manufacturing & Packaging 6. Analytical services.

Otonomy, Inc.

Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The company's core technology is a sustained release formulation developed for optimal delivery of drugs from a single intratympanic (IT) injection. Broad applicability of this delivery and formulation technology has already been established across a number of therapeuti...

Bio-Bridge Science

Bio-Bridge Science, Inc., a development stage biotechnology company, engages in the commercial development of vaccines for the prevention and treatment of human infectious diseases. The company is currently developing and commercializing HIV-PV Vaccine I to prevent and treat infection by the human immunodeficiency virus (HIV). It develops HIV vaccines for both preventive and therapeutic purposes. ...


More From BioPortfolio on "Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks